- Home
- FBIO vs NXPL Comparison
FBIO vs NXPL Comparison
Compare FBIO & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIO
- NXPL
- Stock Information
- Founded
- FBIO 2006
- NXPL 1997
- Country
- FBIO United States
- NXPL United States
- Employees
- FBIO N/A
- NXPL N/A
- Industry
- FBIO Biotechnology: Pharmaceutical Preparations
- NXPL Telecommunications Equipment
- Sector
- FBIO Health Care
- NXPL Telecommunications
- Exchange
- FBIO Nasdaq
- NXPL Nasdaq
- Market Cap
- FBIO 39.4M
- NXPL 32.5M
- IPO Year
- FBIO N/A
- NXPL N/A
- Fundamental
- Price
- FBIO $1.62
- NXPL $0.98
- Analyst Decision
- FBIO Strong Buy
- NXPL
- Analyst Count
- FBIO 3
- NXPL 0
- Target Price
- FBIO $18.00
- NXPL N/A
- AVG Volume (30 Days)
- FBIO 277.9K
- NXPL 83.2K
- Earning Date
- FBIO 03-27-2025
- NXPL 04-10-2025
- Dividend Yield
- FBIO N/A
- NXPL N/A
- EPS Growth
- FBIO N/A
- NXPL N/A
- EPS
- FBIO N/A
- NXPL N/A
- Revenue
- FBIO $81,501,000.00
- NXPL $66,482,000.00
- Revenue This Year
- FBIO N/A
- NXPL N/A
- Revenue Next Year
- FBIO $128.63
- NXPL N/A
- P/E Ratio
- FBIO N/A
- NXPL N/A
- Revenue Growth
- FBIO 31.51
- NXPL 179.89
- 52 Week Low
- FBIO $1.36
- NXPL $0.71
- 52 Week High
- FBIO $2.89
- NXPL $2.68
- Technical
- Relative Strength Index (RSI)
- FBIO 33.40
- NXPL 43.52
- Support Level
- FBIO $1.65
- NXPL $0.96
- Resistance Level
- FBIO $1.85
- NXPL $1.12
- Average True Range (ATR)
- FBIO 0.10
- NXPL 0.09
- MACD
- FBIO -0.01
- NXPL -0.00
- Stochastic Oscillator
- FBIO 7.32
- NXPL 39.13
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.
About NXPL NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.